BB Biotech AG

Schwertstrasse 6
Schaffhausen, SCHAFFHAUSEN, 8200  Switzerland
+41-526240845
Company Type: Joint Stock Company Parent

D&B Business Directory

BB BIOTECH banks on genetics. The investment firm funds private and public biotechnology companies worldwide. BB BIOTECH's portfolio includes significant stakes in about five companies including Actelion, Isis Pharmaceuticals, and Celgene. The company rounds out its portfolio with smaller stakes in another five firms, keeping its holdings below 5%. BB BIOTECH prefers to invest in well-managed small- to mid-sized companies that are within two years of bringing a product to market. It focuses on listed companies. The company has some CHF 2 billion (nearly $2.1 billion) under management. Founded in 1993, BB BIOTECH was an early investor in Amgen, one of the world's biggest biotechnology companies.

Try D&B Hoovers Free
Joint Stock Company Parent
Address
Schwertstrasse 6
Schaffhausen ​, SCHAFFHAUSEN, 8200
Switzerland
See other locations
Phone
+41-526240845
Company Description

BB BIOTECH banks on genetics. The investment firm funds private and public biotechnology companies worldwide. BB BIOTECH's portfolio includes significant stakes in about five companies including Actelion, Isis Pharmaceuticals, and Celgene. The company rounds out its portfolio with smaller stakes in another five firms, keeping its holdings below 5%. BB BIOTECH prefers to invest in well-managed small- to mid-sized companies that are within two years of bringing a product to market. It focuses on listed companies. The company has some CHF 2 billion (nearly $2.1 billion) under management. Founded in 1993, BB BIOTECH was an early investor in Amgen, one of the world's biggest biotechnology companies.

Key Principal
Daniel Koller See more contacts
Industry
Asset Management Finance & Insurance Sector Management investment, open-end
D&B Hoovers Logo

For dynamic search and list-building capabilities, real-time trigger alerts, comprehensive company profiles, and valuable research and technology reports try D&B Hoovers for free!

Financial Statements

Financial data as of December 31, 2019 (12 month period) in USD

Annual Revenue2020
$704.68 million USD
1 USD = 0.9923 CHF

Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.

Competitor Profiles

See detailed profiles for insights and prospects on this company's top competitors.

Company Snapshot

Essential information for a successful call

  •  EMPLOYEES (All Sites) 15
  • ASSETS (MIL USD) 3,994
  •  REVENUE (MIL USD) 704.68
  • TICKER SYMBOL BBZA
  • Year Started 1993
  • Incorporated 1993
  • FISCAL YEAR END DEC
  • SALES GROWTH % 2.04%
  • NET INCOME GROWTH 2.03%

Get in Touch with 9 Principals*

A D&B Hoovers Subscription is your foot in the door to BB Biotech AG contact information.
  • Daniel Koller
    Managing Director and Authorised Signatory
  • Erich Hunziker
    Chairman of the Board
  • Clive Meanwell
    Vice Chairman of the Board
  • David Baltimore
    Authorised Agent

Want more contacts like these available directly in your inbox? Install D&B Email IQ to access your next prospects!

Free Install

Related Products

Grow Business FasterLearn More
D&B Finance Analytics Credit IntelligenceIntelligent Risk ManagementLearn More
Free Microsoft Outlook plugin to drive efficiency with on-demand sales intelligenceFree Install

Get full access to D&B Hoovers

With a Hoovers subscription you can get a comprehensive view of BB Biotech AG

BB Biotech AG*

9
Principals
See who the company's key decision makers are
5
Corporate Relations
Get the big picture on a company's affiliates and who they do business with.
9
Close Industry Peers
See similar companies for insight and prospecting.
*Contacts and Principals counts are estimates and may differ from the actual number of contacts available in D&B Hoovers.